跳至主要内容
临床试验/CTRI/2025/12/099342
CTRI/2025/12/099342
尚未招募
不适用

A randomized comparative clinical trial to evaluate the efficacy of kokilakshadi kwath ghanvati and febuxostat in the management of vatarakta with special reference to gout.

PDEAs College of Ayurveda and Research centre Nigdi Pune1 个研究点 分布在 1 个国家目标入组 70 人开始时间: 2025年12月27日最近更新:

概览

阶段
不适用
状态
尚未招募
发起方
PDEAs College of Ayurveda and Research centre Nigdi Pune
入组人数
70
试验地点
1
主要终点
To compare the effectiveness of kokilakshadi kwath ghanvati 500 mg vyanodan Kal with normal water for 21 days and febuxostat 40 mg once a day after meal with normal water for 21 days in the management of vatarakta with special reference to gout.

概览

简要总结

Health of any individual is depend on their lifestyle.due to poor eating habits like eating junk food which are excessively spicy ,salty ,sore ,pungent ,lack of sleep,excessive travelling and physical exercise and increased exertion in a day to day life.people are more prone to disease among which vatarakta is common presentation.

Due to hetu sevan vatdushti and raktdushti occurs vitiated rakata obstruct the strotasas.due to strotas obstruction, normal gate of vata is obstructed this kupit vayu again vitiate the rakta of whole sharir which leads to vatarakta

Gout is inflammatory and metabolic joint disorder which is caused by deposition of monosodium urate crystal in joints and soft tissues following chronic hyperuricemia.

Kokilakshadi kwath is mentioned in vrundmadhav having all properties may reverse the pathogenesis of vatarakta.

Febuxostat is xanthine oxidase inhibitor which reduces the sr. Uric acid.

研究设计

研究类型
Interventional
分配方式
Coin toss, Lottery, toss of dice, shuffling cards etc
盲法
None

入排标准

年龄范围
35.00 Year(s) 至 65.00 Year(s)(—)
性别
All

入选标准

  • 1.patient whose sr.
  • Uric acid is above 6.8 gm/dl and below 9 gm/dl 2.patients have fulfilling criteria such as sandhi shool ,sandhi stabdhata ,sandhi shoth ,sandhi daha .
  • 3.affected joint especially 1st metatarsophalengial joint other affected joints of body also will be included.

排除标准

  • 1.Known case of amavata 2.known case of sandhigatavata 3.with known case of tuberculosis,HIV,trauma,cardiac disease 4.known case of peripheral vascular disease 5.pregnent and lactating women 6.habitual alcoholic patient 7.patient suffering from secondary gout.

结局指标

主要结局

To compare the effectiveness of kokilakshadi kwath ghanvati 500 mg vyanodan Kal with normal water for 21 days and febuxostat 40 mg once a day after meal with normal water for 21 days in the management of vatarakta with special reference to gout.

时间窗: 21 days with follow up on 8th 15th 22nd day

次要结局

  • To observe and compare the adverse effect in two groups within 21 days(21 days with follow up on 8th 15th 22nd day)

研究者

发起方
PDEAs College of Ayurveda and Research centre Nigdi Pune
申办方类型
Private medical college
责任方
Principal Investigator
主要研究者

Dr Rutuja jijaba Gawade

PDEAs College of Ayurveda and Research centre Nigdi Pune

研究点 (1)

Loading locations...

相似试验